Presentation Operator Message
Operator (Operator)
Good morning and good afternoon, and welcome to the Novartis Q1 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] The
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.36 CHF | +0.43% |
|
-1.54% | +10.73% |
| 03-13 | Novartis Announces FDA Approval for Cosentyx for Pediatric Patients with Moderate to Severe Hidradenitis Suppurativa | CI |
| 03-13 | Novartis Gets FDA Approval for Cosentyx in Pediatric Patients | MT |
Published on 04/29/2025 at 04:20 pm BST - Modified on 04/29/2025 at 01:00 pm BST
Presentation Operator Message
Operator (Operator)
Good morning and good afternoon, and welcome to the Novartis Q1 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] The
Select your edition
All financial news and data tailored to specific country editions